Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Other Non-Current Liabilities (2021 - 2023)

Inmune Bio's Other Non-Current Liabilities history spans 3 years, with the latest figure at $804000.0 for Q3 2023.

  • For Q3 2023, Other Non-Current Liabilities changed N/A year-over-year to $804000.0; the TTM value through Sep 2023 reached $804000.0, changed N/A, while the annual FY2022 figure was $550000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2023 was $804000.0 at Inmune Bio, up from $550000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $804000.0 in Q3 2023 and bottomed at $160000.0 in Q2 2021.
  • The 3-year median for Other Non-Current Liabilities is $397000.0 (2021), against an average of $439500.0.